Terns Pharmaceuticals, Inc. (TERN)
May 5, 2026 - TERN was delisted (reason: acquired by MRK)
52.95
+0.02 (0.04%)
Inactive · Last trade price
on May 4, 2026
Terns Pharmaceuticals Employees
Terns Pharmaceuticals had 59 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
59
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,630,627
Market Cap
6.11B
Employees Chart
TERN News
- 7 weeks ago - Merck Completes Acquisition of Terns Pharmaceuticals, Inc. - Business Wire
- 2 months ago - Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia - GlobeNewsWire
- 2 months ago - Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc. - Business Wire
- 2 months ago - Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders? - PRNewsWire
- 2 months ago - Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. - Business Wire
- 3 months ago - Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 3 months ago - Terns Pharmaceuticals Annual report: Q4 2025 - Filings
- 3 months ago - Terns Pharmaceuticals Transcript: M&A announcement - Transcripts